Eli Lilly's diversified pipeline, rapid tirzepatide growth and rising estimates give it the edge over Novo Nordisk in the obesity drug battle.

The Big 3: AVGO, LLY, GS

12:30pm, Wednesday, 24'th Sep 2025
@Theotrade's Don Kaufman is back on Big 3 — and is bearish on all of today's stocks. He points to exuberant A.I.

2 stocks to reach $1 trillion market cap in 2026

10:47am, Wednesday, 24'th Sep 2025
Amid the ongoing United States stock market rally, several equities have experienced increased buying pressure, pushing their valuations closer to the coveted $1 trillion market capitalization mark.
Eli Lilly Chief Executive Dave Ricks said Britain was "probably the worst country in Europe" for drug prices in an interview with the Financial Times, intensifying pressure on the government to improv
In the closing of the recent trading day, Eli Lilly (LLY) stood at $746.98, denoting a -1.06% move from the preceding trading day.
The planned site, which will be used to manufacture the company's first oral weight-loss drug, is expected to be operational within five years.
Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar manufacturing plant it plans to build in Texas, the company said on Tuesday.
Eli Lilly said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company's pipeline of small molecule drugs, including its closely watched expe
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines  Company plans to create 4,615 manufactu
Funding will strengthen Boys & Girls Clubs serving youth who live on or near federal and state designated Native lands through program support, leadership development and digital transformation Fundin
Celltrion Inc. said in a regulatory filing in South Korea on Tuesday its U.S. subsidiary has acquired Imclone Systems LLC from Eli Lilly in the United States for $330 million.
Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals as it pursues a marketing strategy that is gaining tra
U.S. equities have been volatile this year, but have had a strong run. The S&P 500 index gained 17.3% over the last year through Sept.

3 Stocks Insiders Are Buying Non-Stop

10:00am, Friday, 19'th Sep 2025
Insider buying is one of the few market signals that does not hide behind algorithms or price targets.
Recent breakthroughs in artificial intelligence (AI) are producing tangible results, and not just in the tech industry, although companies in that sector tend to dominate the AI headlines. Even in hea
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE